ebomi
The catalogIssuersInsidersTapeLicence
Colour theme
Theme
Sign in
Insider · CIK 0001557832

Gallagher Cam

CIK 0001557832 Name as filed on the most recent filing

Filed as Gallagher Cam (43)

138 transaction lines · from 43 filings · filed 2020-11-25 to 2025-12-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

138 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-20 05:22 UTC.

Transactions filed by this insider
Direction Date Issuer Code Shares Price Value USD Filing
2021-04-06 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 165 disposed 43.26 7,138.49 Form 4, filing 0001725160-21-000091
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 22,714 disposed 43.41 985,917.07 Form 4, filing 0001725160-21-000091
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,399 disposed 43.37 234,131.41 Form 4, filing 0001725160-21-000091
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 58 disposed 44.21 2,564.46 Form 4, filing 0001725160-21-000091
2021-04-05 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 33 disposed 45.06 1,487.00 Form 4, filing 0001725160-21-000091
2021-03-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 10,000 disposed 41.69 416,858.00 Form 4, filing 0001725160-21-000051
2021-02-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 8,379 disposed 37.38 313,205.34 Form 4, filing 0001725160-21-000021
2021-02-01 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,621 disposed 38.04 61,660.08 Form 4, filing 0001725160-21-000021
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,659 disposed 52.55 192,284.11 Form 4, filing 0001725160-21-000007
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,419 disposed 50.41 121,935.02 Form 4, filing 0001725160-21-000007
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,008 disposed 53.08 106,581.63 Form 4, filing 0001725160-21-000007
2021-01-04 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,914 disposed 51.47 98,522.38 Form 4, filing 0001725160-21-000007
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,103 disposed 54.76 169,935.80 Form 4, filing 0001725160-21-000019
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 6,597 disposed 55.50 366,122.94 Form 4, filing 0001725160-21-000019
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,700 disposed 56.56 322,364.07 Form 4, filing 0001725160-21-000019
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,073 disposed 57.22 175,836.75 Form 4, filing 0001725160-21-000019
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 6,597 disposed Not reported Not priced Form 4, filing 0001725160-20-000062
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,700 disposed Not reported Not priced Form 4, filing 0001725160-20-000062
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,103 disposed Not reported Not priced Form 4, filing 0001725160-20-000062
2020-12-24 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,073 disposed Not reported Not priced Form 4, filing 0001725160-20-000062
2020-12-08 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 13,044 disposed 57.54 750,615.68 Form 4, filing 0001725160-20-000060
2020-12-08 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 4,800 disposed 55.37 265,781.28 Form 4, filing 0001725160-20-000060
2020-12-08 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,226 disposed 56.08 124,836.31 Form 4, filing 0001725160-20-000060
2020-12-08 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,385 disposed 54.19 75,051.76 Form 4, filing 0001725160-20-000060
2020-12-08 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,118 disposed 57.93 64,771.22 Form 4, filing 0001725160-20-000060
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 5,158 disposed 53.71 277,041.85 Form 4, filing 0001725160-20-000060
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,006 disposed 52.53 52,844.48 Form 4, filing 0001725160-20-000060
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 405 disposed 54.39 22,026.45 Form 4, filing 0001725160-20-000060
2020-12-07 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 123 disposed 50.84 6,253.20 Form 4, filing 0001725160-20-000060
2020-12-04 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 4,014 disposed 51.17 205,407.62 Form 4, filing 0001725160-20-000060
2020-12-04 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,460 disposed 50.76 175,638.94 Form 4, filing 0001725160-20-000060
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,468 disposed 50.86 176,397.74 Form 4, filing 0001725160-20-000050
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 3,203 disposed 51.65 165,448.40 Form 4, filing 0001725160-20-000050
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 2,300 disposed 52.71 121,223.34 Form 4, filing 0001725160-20-000050
2020-12-02 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,029 disposed 49.82 51,264.68 Form 4, filing 0001725160-20-000050
2020-11-23 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 8,835 disposed 46.44 410,273.55 Form 4, filing 0001725160-20-000039
2020-11-23 Zentalis Pharmaceuticals, Inc.
ZNTL 		S, Open-market sale 1,165 disposed 47.30 55,107.53 Form 4, filing 0001725160-20-000039
2020-11-19 Ocuphire Pharma, Inc.
OCUP 		P, Open-market purchase 8,865 acquired Not reported Not priced Form 4, filing 0001140361-20-026656

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4. A price the filing did not report is marked Not reported and no value is computed from it. Codes outside the open market, drawn in grey behind a dashed rule, are compensation and administrative machinery rather than a decision to trade at the prevailing price.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 3
  • Open-market sale 135
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Gallagher Cam, insider transactions. Retrieved 2026-08-21 from https://ebomi.com/insider/0001557832

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.